Literature DB >> 12409303

Massive telomere loss is an early event of DNA damage-induced apoptosis.

Rafael Ramírez1, Julia Carracedo, Rosario Jiménez, Andres Canela, Eloísa Herrera, Pedro Aljama, María A Blasco.   

Abstract

Chromosomal stability and cell viability require a proficient telomeric end-capping function. In particular, telomere dysfunction because of either critical telomere shortening or because of mutation of telomere-binding proteins results in increased apoptosis and/or cell arrest. Here, we show that, in turn, DNA damage-induced apoptosis results in a dramatic telomere loss. In particular, using flow cytometry for simultaneous detection of telomere length and apoptosis, we show that cells undergoing apoptosis upon DNA damage also exhibit a rapid and dramatic loss of telomeric sequences. This telomere loss occurs at early stages of apoptosis, because it does not require caspase-3 activation, and it is induced by loss of the mitochondrial membrane potential (Deltapsi(m)) and production of reactive oxygen species. These observations suggest a direct effect of mitochondrial dysfunction on telomeres.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409303     DOI: 10.1074/jbc.M206818200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Mechanisms of dysfunction in senescent pulmonary endothelium.

Authors:  Daniel Jane-Wit; Hyung J Chun
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-05       Impact factor: 6.053

2.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

3.  Green tea compound in chemoprevention of cervical cancer.

Authors:  Changping Zou; Huaguang Liu; Jean M Feugang; Zhengping Hao; H-H Sherry Chow; Francisco Garcia
Journal:  Int J Gynecol Cancer       Date:  2010-05       Impact factor: 3.437

4.  Cell-free DNA and telomere length among women undergoing in vitro fertilization treatment.

Authors:  J Czamanski-Cohen; O Sarid; J Cwikel; A Douvdevani; E Levitas; E Lunenfeld; I Har-Vardi
Journal:  J Assist Reprod Genet       Date:  2015-10-05       Impact factor: 3.412

5.  Telomere attrition and Chk2 activation in human heart failure.

Authors:  Hidemasa Oh; Sam C Wang; Arun Prahash; Motoaki Sano; Christine S Moravec; George E Taffet; Lloyd H Michael; Keith A Youker; Mark L Entman; Michael D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

Review 6.  Molecular regulation of telomerase activity in aging.

Authors:  Craig Nicholls; He Li; Jian-Qiu Wang; Jun-Ping Liu
Journal:  Protein Cell       Date:  2011-10-06       Impact factor: 14.870

7.  Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity.

Authors:  Sutapa Mukherjee Nee Chakraborty; Utpal Ghosh; N P Bhattacharyya; R K Bhattacharya; Subhabrata Dey; Madhumita Roy
Journal:  Mol Cell Biochem       Date:  2006-11-10       Impact factor: 3.396

8.  Telomere shortening and cellular senescence in a model of chronic renal allograft rejection.

Authors:  Simone A Joosten; Vanessa van Ham; Claire E Nolan; Maria C Borrias; Alan G Jardine; Paul G Shiels; Cees van Kooten; Leendert C Paul
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

9.  The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC.

Authors:  Corinna Herz; Anke Hertrampf; Stefan Zimmermann; Nadine Stetter; Meike Wagner; Claudia Kleinhans; Miriam Erlacher; Julia Schüler; Stefanie Platz; Sascha Rohn; Volker Mersch-Sundermann; Evelyn Lamy
Journal:  J Cell Mol Med       Date:  2014-09-25       Impact factor: 5.310

10.  Telomerase confers resistance to caspase-mediated apoptosis.

Authors:  Yira Bermudez; Diana Erasso; Nicole C Johnson; Michelle Y Alfonso; Nancy E Lowell; Patricia A Kruk
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.